HOXC12: A Non-Coding RNA Molecule as A Potential Drug Target (G3228)

Target Name: HOXC12

NCBI ID: G3228

HOXC12

HOXC12: A Non-Coding RNA Molecule as A Potential Drug Target

Homeobox C12 (HOXC12) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of gene expression in various organisms, including humans. The study of HOXC12 and its potential drug targets has generated a lot of interest in the scientific community. In this article, we will provide a comprehensive overview of HOXC12, including its structure, function, and potential drug targets.

Structure and Function

HOXC12 is a non-coding RNA molecule that contains 12 transcribed exons. It is characterized by the presence of a stem-loop structure, which is a common feature of many non-coding RNAs. The stem-loop region of HOXC12 contains a series of conserved core motifs that are involved in the regulation of gene expression.

HOXC12 is a key regulator of gene expression in various organisms, including humans. It has been shown to play a role in the regulation of stem cell proliferation and differentiation, as well as in the development and progression of various diseases, such as cancer.

Potential Drug Targets

HOXC12 has been identified as a potential drug target due to its involvement in the regulation of cell growth and differentiation. Several studies have shown that inhibiting HOXC12 activity can lead to the growth arrest and apoptosis of cancer cells. Additionally, HOXC12 has been shown to play a role in the regulation of stem cell proliferation and differentiation, which makes it an attractive target for drugs that are aimed at treating regenerative diseases.

HOXC12 has also been shown to be involved in the regulation of the immune response, which is a critical function for the regulation of health and disease. The immune response is a critical regulator of cell growth and differentiation, and HOXC12 has been shown to play a role in the regulation of immune cell proliferation and differentiation.

Conclusion

In conclusion, HOXC12 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its structure and function have been extensively studied, and several potential drug targets have been identified. Further research is needed to fully understand the role of HOXC12 in the regulation of gene expression and the development and progression of various diseases.

Protein Name: Homeobox C12

Functions: Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis

The "HOXC12 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HOXC12 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets